Inventor
VELCULESCU VICTOR
US29 patents
⚠️ This page may combine multiple inventors who share the name “VELCULESCU VICTOR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV JOHNS HOPKINS
18 patentsUS7704687B2Apr 27, 2010
Digital karyotyping
UNIV JOHNS HOPKINS116 citations96
US10704108B2Jul 7, 2020
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
UNIV JOHNS HOPKINS22 citations93
US10704105B2Jul 7, 2020
Mutations of the PIK3CA gene in human cancers
UNIV JOHNS HOPKINS13 citations93
US10422006B2Sep 24, 2019
Mutations of the PIK3CA gene in human cancers
UNIV JOHNS HOPKINS13 citations92
US9353418B2May 31, 2016
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
UNIV JOHNS HOPKINS13 citations92
US8026053B2Sep 27, 2011
Mutations of the PIK3CA gene in human cancers
UNIV JOHNS HOPKINS23 citations92
US10900088B2Jan 26, 2021
Personalized tumor biomarkers
UNIV JOHNS HOPKINS23 citations91
US10894987B2Jan 19, 2021
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
UNIV JOHNS HOPKINS5 citations83
US10837064B2Nov 17, 2020
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
UNIV JOHNS HOPKINS9 citations83
US9957572B2May 1, 2018
Personalized tumor biomarkers
UNIV JOHNS HOPKINS5 citations73
US11959142B2Apr 16, 2024
Detection of cancer
UNIV JOHNS HOPKINS2 citations69
US12559802B2Feb 24, 2026
Genomic alterations in the tumor and circulation of pancreatic cancer patients
UNIV JOHNS HOPKINS0 citations55
US10815522B2Oct 27, 2020
Genomic alterations in the tumor and circulation of pancreatic cancer patients
UNIV JOHNS HOPKINS1 citations55
US10982287B2Apr 20, 2021
Response to EGFR blockade
UNIV JOHNS HOPKINS1 citations54
US9926606B2Mar 27, 2018
Tyrosine kinome
UNIV JOHNS HOPKINS0 citations51
US9206467B2Dec 8, 2015
Tyrosine kinome
UNIV JOHNS HOPKINS0 citations51
US9422554B2Aug 23, 2016
MicroRNAome
UNIV JOHNS HOPKINS0 citations50
US8039210B2Oct 18, 2011
Protein tyrosine phosphatase mutations in cancers
UNIV JOHNS HOPKINS0 citations49
VOGELSTEIN BERT
5 patentsUS8685660B2Apr 1, 2014
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
VOGELSTEIN BERT21 citations91
US9982304B2May 29, 2018
ARID1A and PPP2R1A mutations in cancer
VOGELSTEIN BERT4 citations73
US9695479B2Jul 4, 2017
Medulloblastoma genes as targets for diagnosis and therapeutics
VOGELSTEIN BERT2 citations71
US9637779B2May 2, 2017
Antisense transcriptomes of cells
VOGELSTEIN BERT0 citations50
US10144971B2Dec 4, 2018
Genes frequently altered in pancreatic neuroendocrine tumors
VOGELSTEIN BERT1 citations49
PERSONAL GENOME DIAGNOSTICS INC
2 patentsUS10563266B2Feb 18, 2020
Neoantigen treatment prioritization using multivariate analysis based on: HLA genotype, self-similarity, similarity to known antigens, antigen expression levels and mutant allele frequency
PERSONAL GENOME DIAGNOSTICS INC2 citations68
US12331361B2Jun 17, 2025
Methods and systems for identification and prioritization of mutation-derived neoantigens
PERSONAL GENOME DIAGNOSTICS INC0 citations57